此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Ventilator Study in the NICU

2026年5月8日 更新者:Håkan Björne

Titration of End-expiratory Lung Volume Using the Capnodynamic Method in Intubated Neurointensive Care Patients - Effects on Driving Pressure, Compliance, and Mixed Venous Oxygen Saturation

Background:

Optimal adjustment of mechanical ventilation in intensive care patients is crucial to ensure effective ventilation and to reduce the risk of ventilator-associated complications such as pneumonia and ventilator-induced lung injury. Current monitoring methods may often be insufficient to achieve truly optimal ventilator settings in routine clinical practice. By applying a specific breathing pattern, additional key ventilation-related parameters can be monitored and adjusted using a novel carbon dioxide-based method. This approach has the potential to substantially improve ventilation in critically ill patients.

The carbon dioxide-based method utilizes a modified intensive care ventilator (Servo-i®, Getinge) equipped with CE-marked research software. The software modifies the breathing pattern by introducing three slightly prolonged expiratory pauses in three out of nine breaths. This ventilator has been used in multiple large-animal studies and clinical trials, including two conducted by the present research group.

Study Design:

The study will include adult patients receiving mechanical ventilation in a neurointensive care unit due to brain injury. Patients must be in a stable phase with regard to neurological status and circulation and require controlled mechanical ventilation. Informed consent will be obtained from the patient after recovery when applicable.

Part 1 (Pilot Study):

This is an observational study including 15 patients, aiming to establish reference values for parameters obtained using the carbon dioxide-based method, such as end-expiratory lung volume and mixed venous oxygen saturation. Patients will be switched to the research ventilator for 15-20 minutes, during which measurements from the carbon dioxide-based method and standard vital sign monitoring will be collected. Ventilator settings will be identical to those used on the patient's conventional ventilator. After completion of the protocol, patients will be switched back to their standard ventilator.

Part 2 (Main Study):

This is an interventional study with a within-subject (self-controlled) design, including 15 mechanically ventilated patients with stable brain injury. The aim is to optimize ventilator settings using the carbon dioxide-based method to achieve more lung-protective ventilation.

Patients will be transferred to the research ventilator using the same procedure as in the pilot study, initially maintaining the same ventilator settings. After a 10-minute stabilization period, ventilatory parameters will be recorded and an arterial blood gas sample obtained (baseline). The specific breathing pattern will then be initiated, and ventilation will be adjusted based on additional parameters provided by the capnodynamic method (end-expiratory lung volume, cardiac output, and mixed venous oxygen saturation). Measurements and arterial blood gases will be repeated immediately after initiation of the breathing pattern and again 15 minutes after ventilator adjustments. The study will then conclude, and the patient will be returned to their standard ventilator using the optimized ventilator settings to potentially ensure patient benefit.

研究概览

地位

尚未招聘

详细说明

The primary outcome measure is a reduction in driving pressure, as it is well established that a driving pressure >15 cmH₂O is associated with an increased risk of lung injury (ventilator-induced lung injury, VILI). Clinical observations in the intended study population show driving pressures of approximately 19 cmH₂O with an estimated standard deviation of 2 cmH₂O (study baseline). When these values are entered into a power calculation for a paired two-sided t-test, a sample size of approximately 10 patients is obtained. To account for potential dropouts, the study group size is set at 15 patients. The significance level is <0.05, with a power of 80%.

研究类型

介入性

注册 (估计的)

30

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

      • Stockholm、瑞典
        • Karolinska University Hospital, Neurointensive care unit
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Stable with regard to intracranial pressure
  • Hemodynamically stable

Exclusion Criteria:

  • Ongoing instability with regard to intracranial pressure and circulation
  • Spontaneous breathing / patient-triggered ventilation
  • If the patient subsequently declines consent

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Single group vetilation arm, both for pilot and main study
Intervention i main study will be adjusting ventilator settings using capnodynamic parameters to minimize driving pressure.
Applying the capnodynamic method using a modified intensive care ventilator and subsequently use additional parameters like effective lung volume (ELV) in order to adjust ventilator settings to minimize driving pressure.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Driving pressure (deltaP) cmH2O.
大体时间:Study protocols will have a time frame och 15-30 minutes.
Difference in driving pressure (dP) before and after ventilatory adjustments.
Study protocols will have a time frame och 15-30 minutes.

次要结果测量

结果测量
措施说明
大体时间
ELV (ml)
大体时间:15-30 minutes
Normal values of effective lung volume (ELV) with patients int 30 degrees head up position.
15-30 minutes

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年6月1日

初级完成 (估计的)

2027年6月1日

研究完成 (估计的)

2027年8月1日

研究注册日期

首次提交

2026年5月3日

首先提交符合 QC 标准的

2026年5月8日

首次发布 (实际的)

2026年5月13日

研究记录更新

最后更新发布 (实际的)

2026年5月13日

上次提交的符合 QC 标准的更新

2026年5月8日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

其他研究编号

  • CIV-ID CIV-26-01-055996
  • 2026-01383-01 (其他标识符:Swedish Ethical Review Authority)

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅